Naxos disease patients were among the first ARVC patients whose myocardial samples were subjected to immunohistochemistry analyses, revealing that mutant JUP is expressed (as evidenced by Western immunoblotting) but fails to localize at the cardiac intercalated disks (IDs) (Figure 4, 2C).17 The gene discussed is JUP; the disease is Naxos disease.